APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
2022 · Molecular Neurodegeneration · 248 citations
https://doi.org/10.1186/s13024-022-00566-4
A
Antonio Boza‐Serrano
Lund University(SE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
3.4K
Citations
23
h-index
27
i10-index
Antonio Boza‐Serrano is an academic researcher from Lund University. The author has contributed to research in topics: Neuroinflammation and Neurodegeneration Mechanisms & Galectins and Cancer Biology & Parkinson's Disease Mechanisms and Treatments. The author has an h-index of 23, co-authored 38 publications.
ORCID: 0000-0003-2121-2486Papers by this author
worksTargeting Neuroinflammation to Treat Alzheimer’s Disease
2017 · CNS Drugs · 224 citations
https://doi.org/10.1007/s40263-017-0483-3
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease
2022 · Acta Neuropathologica · 54 citations
https://doi.org/10.1007/s00401-022-02469-6
FGF family members differentially regulate maturation and proliferation of stem cell-derived astrocytes
2019 · Scientific Reports · 51 citations
https://doi.org/10.1038/s41598-019-46110-1
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
2023 · Acta Neuropathologica · 34 citations
https://doi.org/10.1007/s00401-023-02585-x
Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer’s disease
2023 · Translational Neurodegeneration · 18 citations
https://doi.org/10.1186/s40035-023-00338-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat